Framework · Contracts Finder
Exact Sciences - Oncotype DX Breast Recurrence Score tests
Groups 2 related procurements, worth £340.2k combined.
- 2
- Member contracts
- £340.2k
- Combined value
- 1
- Buyers
Exact Sciences - Oncotype DX Breast Recurrence Score tests is a UK public-sector framework or programme that groups 2 related procurements worth £340.2k combined. The member contracts and call-offs below are run by 1 participating buyer.
Details
- Source
- Contracts Finder
- Member contracts
- 2
- Combined value
- £340,202
- First activity
- 23 Apr 2024
- Latest activity
- 23 Apr 2024
- Participating buyers
- 1
Member procurements
Contracts and call-offs grouped under this framework.
Participating buyers
FAQs about this framework
What is the "Exact Sciences - Oncotype DX Breast Recurrence Score tests" framework?
It groups 2 related UK public procurements worth £340,202 combined, published via Contracts Finder.
Which buyers use this framework?
1 buyer participate, including Norfolk and Norwich University Hospitals NHS Foundation Trust.
When is this framework active?
Recorded activity runs from 23 Apr 2024 to 23 Apr 2024.
Get ahead on framework opportunities
Enable tracks frameworks and their call-offs across UK public procurement so you can position before the next mini-competition. Talk to us.
Get in touch with Enable